Corporate governance, shareholder rights, and shareholder rights plans: Poison, placebo, or prescription?

Journal of Financial and Quantitative Analysis

Volumn 43, Issue 2, 2008, Pages 381-400

  Caton, Gary L ^a   Goh, Jeremy ^b  

^a MONTANA STATE UNIVERSITY   (United States)

^b SINGAPORE MANAGEMENT UNIVERSITY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 46849092993     PISSN: 00221090     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0022109000003562     Document Type: Article

References (39)

1. Amihud, Y., and B. Lev. "Risk Reduction as a Managerial Motive for Conglomerate Mergers." Bell Journal of Economics, 12 (1981), 650-657.
2. Andrade, G.; M. Mitchell; and E. Stafford. "New Evidence and Perspectives on Mergers." Journal of Economic Perspectives, 15 (2001), 103-120.
3. Bebchuk, L. A. "The Case for Increasing Shareholder Power." Harvard Law Review, 118 (2005), 833-917.
4. Bebchuk, L. A.; J. C. Coates IV; and G. Subramanian. "The Powerful Antitakeover Force of Staggered Boards: Theory, Evidence and Policy." Stanford Law Review, 54 (2002), 887-951.
5. Bebchuk, L. A.; A. Cohen; and A. Ferrell. "What Matters in Corporate Governance." Working Paper, Harvard University (2004).
6. Black, F. "Noise." Journal of Finance, 41 (1986), 529-543.
7. Brickley, J. A.; J. L. Coles; and R. L. Terry. "The Board of Directors and the Enactment of Poison Pills." Journal of Financial Economics, 35 (1994), 371-390.
8. Brous, P. A. "Common Stock Offerings and Earnings Expectations: A Test of the Release of Unfavorable Information." Journal of Finance, 47 (1992), 1517-1536.
9. Brous, P. A., and O. Kini. "Interfirm Tender Offers and Target Firms' Future Performance: A Reexamination of Analysts' Earnings Forecasts." Journal of Financial Economics, 34 (1993), 201-225.
10. Chi, J. "Understanding the Endogeneity between Firm Value and Shareholder Rights." Financial Management, 34 (2005), 65-76.
11. Coates, J. C. IV. "The Contestability of Corporate Control: A Critique of the Scientific Evidence on Takeover Defenses." Discussion Paper No. 265, Harvard University (1999).
12. Comment, R., and G. W. Schwert. "Poison or Placebo? Evidence on the Deterrence and Wealth Effects of Modern Antitakeover Measures." Journal of Financial Economics, 39 (1995), 3-43.
13. Danielson, M. G., and J. M. Karpoff. "Do Pills Poison Operating Performance?" Journal of Corporate Finance, 12 (2006), 536-559.
14. Datta, S., and M. Iskandar-Datta. "Takeover Defenses and Wealth Effects on Securityholders: The Case of Poison Pill Adoptions." Journal of Banking and Finance, 20 (1996), 1231-1250.
15. DeAngelo, H., and L. DeAngelo. "Management Buyouts of Publicly Traded Corporations." Financial Analysts Journal, 43 (1987), 38-49.
16. Denis, D. J., and D. K. Denis. "Performance Changes Following Top Management Dismissals." Journal of Finance, 50 (1995), 1029-1057.
17. Gompers, P. A.; J. L. Ishii; and A. Metrick. "Corporate Governance and Equity Prices." Quarterly Journal of Economics, 118 (2003), 107-155.
18. Heron, R. A., and E. Lie. "On the Use of Poison Pills and Defensive Payouts by Takeover Targets." Journal of Business, 79 (2006), 1783-1807.
19. Jarrell, G. A.; J. A. Brickley; and J. M. Netter. "The Market for Corporate Control: The Empirical Evidence Since 1980." Journal of Economic Perspectives, 2 (1988), 49-68.
20. Jensen, M. C. "Agency Costs and Free Cash Flow, Corporate Finance, and Takeovers." American Economic Review, 76 (1986), 323-329.
21. Jensen, M. C., and W. H. Meckling. "Theory of the Firm: Managerial Behavior, Agency Costs and Ownership Structure." Journal of Financial Economics, 3 (1976), 305-360.
22. Jensen, M. C., and R. S. Ruback. "The Market for Corporate Control: The Scientific Evidence." Journal of Financial Economics, 11 (1983), 5-50.
23. Knoeber, C. R. "Golden Parachutes, Shark Repellents, and Hostile Tender Offers." American Economic Review, 76 (1986), 155-167.
24. Lehn, K.; S. Patro; and M. Zhao. "Governance Indices and Valuation: Which Causes Which?" Working Paper, University of Pittsburgh (2006).
25. Levitt Jr., A. "The Imperial CEO is No More." The Wall Street Journal (March 17, 2005), A-16.
26. Malatesta, P. H., and R. A. Walkling. "The Impact of Poison Pill Securities on Stockholder Wealth." Working Paper, University of Washington (1985).
27. Malatesta, P. H., and R. A. Walkling. "Poison Pill Securities: Stockholder Wealth, Profitability, and Ownership Structure." Journal of Financial Economics, 20 (1988), 347-376.
28. McConnell, J. J., and C. J. Muscarella. "Corporate Capital Expenditure Decisions and the Market Value of the Firm." Journal of Financial Economics, 14 (1985), 399-422.
29. Morgenson, G. "Shares of Corporate Nice Guys Can Finish First." The New York Times (April 27, 2003), 3.1.
30. O'Brien, P. C. "Analysts' Forecasts as Earnings Expectations." Journal of Accounting and Economics, 10 (1988), 187-221.
31. Plitch, P. "TIAA-CREF Targets 'Dead-hand' Poison Pills." The Wall Street Journal (January 31, 2000), 1.
32. Rosenbaum, V. Corporate Takeover Defenses, Investor Responsibility and Research Center, Washington, DC (1990), (1993), (1995), (1998), (2000), (2002), and (2004).
33. Ryngaert, M. D. "The Effects of Poison Pill Securities on Shareholder Wealth." Journal of Financial Economics, 20 (1988), 377-417.
34. Schwert, G. W. "Markup Pricing in Mergers and Acquisitions." Journal of Financial Economics, 41 (1996), 153-192.
35. Schwert, G. W. "Hostility in Takeovers: In the Eyes of the Beholders?" Journal of Finance, 55 (2000), 2599-2640.
36. Stein, J. C. "Takeover Threats and Managerial Myopia." Journal of Political Economy, 96 (1988), 61-80.
37. "Where Should Investors Turn? There's Little Consistency When it Comes to Ratings of Corporate Governance." The Wall Street Journal (June 17, 2004), C-1.
38. Weisbach, M. "Outside Directors and CEO Turnover." Journal of Financial Economics, 20 (1988), 431-461.
39. Weston, J. F.; M. L. Mitchell; and J. H. Mulherin. Takeovers, Restructuring, and Corporate Governance, 4th ed. Upper Saddle River, NJ: Pearson Education Inc. (2004).